Norwegian Society of Hypertension
Course on arterial hypertension
Trondheim November 25.-26. 2010.
PROGRAMME
25.04.10
10.00-10.15
Introduction
Chair: Dr. Rune Mo MD PhD; University Hospital of Trondheim.
President of the Norwegian Society of Hypertension (NSH),
Prof. Eva Gerdts MD PhD; Haukeland University Hospital, Bergen.
10.15–12.15
Hypertension - epidemiology and pathophysiology.
Chair: Prof. Sverre E. Kjeldsen MD PhD; Oslo University Hospital Ullevål.
10.15-10.45
Why is blood pressure decreasing in the population?
Trends in prevalence and treatment of arterial hypertension.
Dr. Jostein Holmen MD PhD; HUNT, University of Trondheim.
10.45-11.15
Hypertension – an inappropriate relationship between cardiac output and peripheral
resistance.
Prof. Per Lund – Johansen MD PhD; Haukeland University Hospital, Bergen.
11.15-11.30
Which part does the kidney play in the development of essential hypertension?
Research fellow Michael Hultström MD; Haukeland University Hospital, Bergen.
11.30–11.45
The autonomic nervous system and hypertension – unsympathetic hyperactivity?
Dr. Arnljot Flaa MD PhD; Oslo University Hospital Ullevål.
11.45-12.15
Hypertension, the metabolic syndrome and diabetes mellitus.
Dr. Tonje Amb Aksnes MD PhD; Oslo University Hospital Ullevål.
12.15 – 13.15 LUNCH
13.15-14.45
Blood pressure measurement.
Chair: Eva Gerdts.
13.15–13.30
Conventional blood pressure measurement.
Rune Mo.
13.30-13.45
How is blood pressure measurement actually performed in general practices?
Dr. Nils Moe MD; University of Trondheim.
13.45-14.00
Which patients should be selected for home blood pressure measurement?
Sverre E. Kjeldsen.
14.00-14.15
Should all patients with mild hypertension perform 24-hour blood pressure measurement?
Prof. Ingrid Os MD PhD; Department of nephrology, Oslo University Hospital Ullevål.
14.15-14.45
Discussion and case presentations.
14.45-15.00 RECESS
15.00-16.30
Examination and assessment of target organ damage.
Chair: Michael Hultström.
15.00-15.15
Hypertension – what should be included in the initial examination?
Prof. Ingrid Toft MD PhD; University Hospital of North Norway, Tromsø.
15.15-15.30
Secondary hypertension – an overview.
Ingrid Toft.
15.30-16.00
Hypertension and the heart. What is the link, and who should be referred to a cardiologist?
Eva Gerdts.
16.00-16.30
Hypertension and the kidneys. What is the link, and who should be referred to a nephrologist?
Ingrid Os.
16.30-17.00 RECESS
17.00-18.00 Chair: Eva Gerdts.
17.00–17.40
Norwegian guidelines for primary prophylaxis of cardiovascular disease 2009.
Are they up-to-date?
Sverre E. Kjeldsen.
17.40-18.00
Discussion.
26.04.10
08.30-10.20
Hypertension i special populations.
Chair: Ingrid Toft.
08.30-08.50
Hypertension in the young.
Research fellow John Munkhaugen; University of Trondheim.
08.50-09.10
Hypertension in the elderly.
Per Lund-Johansen.
09.10-09.30
White-coat hypertension.
Prof. Per Omvik MD PhD; Haukeland University Hospital, Bergen.
09.30-09.50
Hypertension and stroke.
Prof. Bent Indredavik MD PhD; University Hospital of Trondheim.
09.50-10.20
Discussion and case presentations.
10.20-10.50 RECESS
10.50 -11.50
Non-pharmacological treatment.
Chair: Rune Mo.
10.50–11.10
How can blood pressure be lowered without drugs?
Tonje A. Aksnes.
11.10-11.30
Exercise to lower blood pressure - how and how much?
Associate prof. Asbjørn Støylen MD PhD; University of Trondheim.
11.30–11.40
Discussion and case presentations.
11.40 -12.40 LUNCH
12.40-15.00
Drug treatment.
Chair: Per Omvik.
12.40-13.00
Treatment of arterial hypertension from rice diet to the hypertension vaccine
– an historical overview.
Per Lund-Johansen.
13.00–13.30
What can be expected from drug treatment in terms of benefit?
Evidence and current guidelines.
Rune Mo.
13.30–13.50
Why should target blood pressure be achieved?
Eva Gerdts.
13.50–14.10
Complicated, resistant and secondary hypertension – treatment aspects.
Associate prof. Stein Hallan MD PhD; NTNU/St Olavs Hospital, Trondheim
14.10-14.30
Treatment of hypertension with target organ damage, cardiorenovascular disease, or other coexistent conditions.
Ingrid Toft.
14.30-15.00
Disussion and case presentations.
15.00–15.20 RECESS
15.20–15.40
Course test.
Chair: Michael Hultström.
15.40-15.50
Course evaluation.
Chair: Rune Mo
15.50–16.00
Closure.
Chair: Rune Mo.
President of the NSH, Eva Gerdts.